OpinionViewpoints

It Is Time to Face Reality About the Vaccines

Save
It Is Time to Face Reality About the Vaccines
Vials of the COVID-19 vaccine by Moderna (C) and Pfizer/BioNTech against the novel coronavirus stand on a table in a vaccination center in Sonthofen, Germany, on Nov. 30, 2021. Christof Stache/AFP via Getty Images
Vinay Prasad
Updated:
Commentary

A number of studies are converging on the fact that 2 doses of vaccination has poor vaccine effectiveness against Omicron. 3 doses does slightly better, but the effect will rapidly wane as antibody titers fall, and infection is certain as the number of exposures increase. These studies have immediate implications for vaccine and health-care policies.

Vinay Prasad
Vinay Prasad
Author
Vinay Prasad M.D. MPH is a hematologist-oncologist and associate professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco. He runs the VKPrasad lab at UCSF, which studies cancer drugs, health policy, clinical trials, and better decision making. He is author of over 300 academic articles, and the books “Ending Medical Reversal” (2015), and “Malignant” (2020).
Related Topics